Eric Schnaith, M.D.

Eric Schnaith, M.D.

Amy Down, D.O.Подробнее

Amy Down, D.O.

Cardiac Rehabilitation - Eric Sontz, MD, Eisenhower Desert Cardiology CenterПодробнее

Cardiac Rehabilitation - Eric Sontz, MD, Eisenhower Desert Cardiology Center

Eric Ingerowski, MD - Fast and AccurateПодробнее

Eric Ingerowski, MD - Fast and Accurate

Practical Management of Erectile Dysfunction, What is the latest Upate? Charalamos Konstantinidis MDПодробнее

Practical Management of Erectile Dysfunction, What is the latest Upate? Charalamos Konstantinidis MD

Point of the match - Sergei Sirant vs Adrian Dziolko - ECC 2018Подробнее

Point of the match - Sergei Sirant vs Adrian Dziolko - ECC 2018

Erik Schnaser, MD - IntroductionПодробнее

Erik Schnaser, MD - Introduction

Meet Dr. Eric Weisman, MDПодробнее

Meet Dr. Eric Weisman, MD

Eric S Hungness, MDПодробнее

Eric S Hungness, MD

The Drug Trial Process with Dr. Eric Jacobsen in 2018Подробнее

The Drug Trial Process with Dr. Eric Jacobsen in 2018

NDT Edu Webinar - ABPM for the diagnosis and the monitoring of hypertension in dialysisПодробнее

NDT Edu Webinar - ABPM for the diagnosis and the monitoring of hypertension in dialysis

Eric Jonasch, MD, on approaches to consider with metastatic non-clear renal cell carcinomaПодробнее

Eric Jonasch, MD, on approaches to consider with metastatic non-clear renal cell carcinoma

Eric Jonasch, MD, on integrating immunotherapies into renal cell carcinoma treatment algorithmsПодробнее

Eric Jonasch, MD, on integrating immunotherapies into renal cell carcinoma treatment algorithms

Eric Moskowitz, MDПодробнее

Eric Moskowitz, MD

Meet Eric England, MDПодробнее

Meet Eric England, MD

Eric Aschenbrenner, MDПодробнее

Eric Aschenbrenner, MD

Meet Eric Nuebel, P.A.-C. – Mayo Clinic Health SystemПодробнее

Meet Eric Nuebel, P.A.-C. – Mayo Clinic Health System

Meet Brian Gerhardstein, M.D., Ph.D., a board-certified neurologistПодробнее

Meet Brian Gerhardstein, M.D., Ph.D., a board-certified neurologist

Eric Jonasch, MD, on which non-metastatic renal cell cancer patients should receive adjuvant therapyПодробнее

Eric Jonasch, MD, on which non-metastatic renal cell cancer patients should receive adjuvant therapy